Thursday, 21 August 2003: 08:00-17:00
River Exhibition Hall (Sheraton Hotel and Towers)

PD Thursday Poster Sessions

PD-001 Incipient Alzheimer's Disease in Patients with Mild Cognitive Impairment Can be Detected by CSF Levels of Total Tau, Phospho Tau and Ab42
Niels Andreasen, Bengt Winblad, Kaj Blennow
PD-002 Decreased NAA Levels in the Hippocampus of People with Mild Cognitive Impairement
Malgorzata Franczak, Robert Robert Prost, John Ulmer, Leighton Mark, Piero Antuono
PD-003 Apathetic Hyperthyroidism in the Elderly: A Case Report
José Eduardo Martinelli, Ivan Aprahamian, Renata Vasconcellos Regazzini
PD-004 Decreased Risk of First Antipsychotic Drug use in Patients with Alzheimer's Disease Treated with Rivastigmine
Dong-Churl Suh, Stephen Arcona, Simu K Thomas, Christopher Powers, Adrian Rabinowicz, Dario Mirski
PD-005 The Rates and the Correlates of Alcohol Use Disorders Among the Elderly in Korea
Jae Nam Bae, Min Hee Kang, Churl Eung Kim, Bong Jin Hahm, Maeng Je Cho
PD-006 Behavioral Effects of Subchronic Memantine Treatment in APP/PS1 Double Mutant Mice Modeling Alzheimer’s Disease
Heikki Tanila, Rimante Minkeviciene, Pradeep Banerjee
PD-007 Hearing Impairment and Mental Health
Bello Bello Bala
PD-008 Differences in Basal Cortisol Levels in a Geriatric Psychiatry Inpatient Population with Dementia and Depression
Lesley Blake
PD-009 Rapid Remission of Severe Tardive Dyskinesia and Tardive Dystonia in a 62 Year Old Patient with a Schizo-Affective Illness Using Quetiapine
Filip Bouckaert, Griet Herman
PD-010 Risperidone is Effective in the Treatment of BPSD Irrespective of the Type and Severity of Dementia
Henry Brodaty, Peter De Deyn, Ira Katz, Ben Lyons, Grant Ko
PD-011 Living with Alzheimer's Disease
Carlo Cristini, Giovanni Cesa-Bianchi
PD-012 Use of Psychotropic Drugs in Older People with Mental Illness
Stephen Curran
PD-013 Risperidone Improves Psychotic Symptoms in Elderly Patients with Psychosis of Alzheimer’s Disease and Related Dementias
Peter P De Deyn, Ira Katz, Henry Brodaty, Ben Lyons, Grant Ko
PD-014 Risperidone Reduces Aggressive Symptoms Associated with Dementia Independent of Its Antipsychotic Effect or Induction of Somnolence
Peter P De Deyn, Ira Katz, Henry Brodaty, Ben Lyons, Grant Ko
PD-015 Smoking Behavior and Dementia Development in a Community-Based Cohort of Elderly African-Americans
Jeanne I. Dickens, Sujuan Gao, Kathleen S Hall, Hugh Hendrie
PD-016 The Effect of Bright Light Therapy on the Sleep-Wake Rhythm in Institutionalized Patients with Alzheimer’s Disease
Glenna A. Dowling, Erin M. Hubbard, Judy Mastick, Jay S. Luxenberg, Eus J. W. Van Someren, Shirley Wu
PD-017 Alcohol Consumption in Primary Care Elderly Patients: Demographic Characteristics and Comorbidities
U. Nalla Banu Durai, John S. McIntyre, Karen Lynn Cheal, Elizabeth Catherine McDonel Herr, Sue Ellen Levkoff
PD-018 A Systematic Review of the Evidence for Behavior Rating Scales as Treatment
Chris Edwards, George Christopher Fox
PD-019 Mentally Ill Elderly and Their Caregivers’ Views on Spiritual Care
George El-Nimr, Steve Bradshaw, E. Jane Byrne
PD-020 Professionals' Views on Spirituality
George El-Nimr, Laura Green, Emad Salib
PD-021 Use of Intramuscular Ziprasidone in Geriatric Patients With Acute Psychosis
Bijan Etemad
PD-022 The Effect of Galantamine on Behavior Changes in Patients with Vascular Dementia and Alzheimer's Disease with Cerebrovascular Disease
Howard Feldman, Sean Lilienfeld, Atul R. Mahableshwarkar
PD-023 Individually Adjusted Treatment of BPSD Patients
Benny Fhager, Inga-Maj Meiri, Åke Edman, Clary Holtendal
PD-024 Galantamine Use in Alzheimer's Disease: A Novel Antiapoptotic Mechanism Linked to Up-Regulation of Bcl-2 and a7 Receptors
Manuela Garcia-Lopez
PD-025 A Pilot Study on the Effect of Estrogen-Progestin Replacement Therapy on Brain Dopamine Transporter Activity in Healthy, Postmenopausal Women
Sara Anne Gardiner, Mary Frances Morrison, P. David Mozley, Lyn Harper Mozley, Colleen Brensinger, Michelle Battistini, Warren Bilker
PD-026 Cognitive Impairment is the Main Predictor of Functional Status in a Geriatric Institutionalized Population
Ricardo Oliveira Guerra, Carmen Villaverde Gutierrez
PD-027 Efficacy and Safety of Higher Olanzapine Doses in Acutely Agitated Elderly Patients
Donald Hay, Eva Marquez, Hillary McGuire, Catherine Zofkie
PD-028 Cognitive Function in Patients with Alzheimer’s Dementia During Double-Blind Treatment of Psychosis with Olanzapine
Donald P. Hay, Walter Deberdt, Peter P DeDeyn, Manuel M Carrasco, Claude Jeandel, Peter D. Feldman, Carrie A. Young, Deborah L Lehman, Alan Breier
PD-029 Olanzapine Versus Placebo in the Treatment of Psychosis with or without Associated Behavioral Disturbances in Patients with Alzheimer’s Dementia
Vicki Poole Hoffmann, Peter P DeDeyn, Manuel M Carrasco, Walter Deberdt, Claude Jeandel, Donald P. Hay, Peter D. Feldman, Carrie A. Young, Deborah L Lehman, Alan Breier
PD-030 Memantine Restores Okadaic Acid-Induced Changes in the Activities of Protein Phosphatase-2A, CaMKII and Hyperphosphorylation of Tau in Rat Hippocampal Slices in Culture
Khalid Iqbal, Liang Li, Amitabha Sengupta, Inge Grundke-Iqbal
PD-031 Psychological Well Being in the Elderly Suffering Chronic Pain
Lepa Bosko Jovanovic
PD-032 Low Bone Mineral Density Associated with Increased Prolactin and Aging in Psychiatric Patients Treated with Prolactin-Elevating Antipsychotics
Bruce J. Kinon, Hong Liu, Jonna Ahl, Shaw Lamberson
PD-033 Several Statistical Data That Are Troubling…
Arpine Kirakosyan
PD-034 Pooled Analysis of the Safety and Tolerability Profile of Aripiprazole in Schizophrenia
Dusan Kostic, Robert D. McQuade, Anutosh R. Saha, Stephen B. Kaplita, Donald G. Archibald, Taro Iwamoto, Elyse Stock
PD-035 Oral Morphine Successfully Treats Behavioral Symptoms in Severe Dementia: A Case Series
Susan Elizabeth Kurrle, Ian Douglas Cameron, John Snowdon
PD-036 Multimorbidity in a Geropsychiatric Unit in 2001
Vladimirs Kuznecovs
PD-037 The Longitudinal Study on Aging: Relationships Between Self-Reported Confusion in Community Dwelling Elderly and Time to Death
Helen H. Kyomen, John Hennen
PD-038 Effect of Memantine on Levels of the Amyloid Beta Peptide in Cell Cultures
Debomoy K Lahiri, George M. Alley, Cindy Morgan, Pradeep Banerjee, Martin R. Farlow
PD-039 Baseline Aggression and Noradrenergic Responsiveness Predict Decreased Aggression Following Pindolol in Alzheimer's Disease
Krista L. Lanctôt, Nathan Herrmann, Goran M. Eryavec, Lyla R. Khan
PD-040 Stable Elderly Patients with Psychotic Disorders Improve with Long-Acting Risperidone
Robert Lasser, Cynthia Bossie, Marielle Eerdekens, Young Zhu, Georges Gharabawi
PD-041 Acetylcholinestrase Inhibitor and Unpleasant Dreams
Namjin Lee
PD-042 Rivastigmine in Schizophrenia: Effects on Quality of Life
Alessandro Lenzi, Elisabetta Maltinti, Enzo Poggi, Lazzerini Fabrizio, Elisabetta Coli
PD-043 Atypical Antipsychotics Attenuate the Neurotoxicity of MPP+ and Beta-Amyloid in PC12 Cells
Zelan Wei, Darrell Mousseau, Hong Qing, Zhong-Jun Shao, Lillian Dyck, Xin-Min Li
PD-044 Selective Hypoperfusion of Cingulate Gyrus in Alzheimer Patients with Depression: A Brain SPECT Finding by Statistical Parametric Mapping
Hsiu-Chih Liu, Ti-Chu Liao, Ren-Shyan Liu, Yi-Chung Lee, Pei-Ning Wang
PD-045 Utilization of Ziprasidone in Elderly Nursing Facility Residents
Antony Loebel, Joan A. Mackell, Sharon B. Dybicz, W. Gary Erwin
PD-046 Blocking of the Genetic Mechanisms of Brain Aging and Displacement of a Lifespan up to 200-300 Years
Ye. Lokhov Rudolf
PD-047 Systematic Review of Dementia Prevalence from 1994 to 2000
Marcos Antonio Lopes, Cássio Machado de Campos Bottino
PD-048 Effective Remedy for Alzheimer’s Disease Personalized Treatment, “Adement”
Alexander Makarenko
PD-049 Management of Late Life Mood Disorders in Healthy Persons
Mukul K Manna
PD-050 Galantamine as an Adjunctive Therapy in the Treatment of Schizophrenia
Joseph McEvoy, Trina Allen
PD-051 Effect of Divalproex Sodium on Behavioral and Cognition Problems in the Elderly
Jane M Meinhold, Jeffrey A Welge, Michael Schwiers, Jonathan Musher, Anthony Hughes, Louis J Mini, Suzanne C Giordano
PD-052 The Prevalence of Depressive Symptoms Among Elderly at Home Treatment and Care
Aleksandra Milicevic-Kalasic
PD-053 A Novel Fast-Disintegrating Oral Formulation of the Atypical Antipsychotic Risperidone
Jacobo Mintzer, Phillipe Lechat, Bart M.M. Remmerie, Erik Mannaert
PD-054 Effects of Rivastigmine on Disruptive Behavior Associated with Alzheimer’s Disease
Jacobo Mintzer, Roger Lane, Rene Spiegel, Sibel Tekin, Peter Quarg
PD-055 Galantamine Reduces Behavioral and Psychological Disturbances and Behavior-Related Caregiver in Mild-to-Moderate Alzheimer's Disease
Andreas U. Monsch, Eva Krebs-Roubicek, Daniel Braendle, Christoph Hock
PD-056 Saccadic Eye Movements in Dementia with Lewy Bodies
Urs P Mosimann, Jacques Felblinger, René M Müri, Louise Allan, Sanjeet Pakrasi, Lorraine C Bowman, John T O'Brien
PD-057 Importance of Occupation for the Well-Being in the Elderly
Helena Palma-Reis, Inês Palma-Reis
PD-058 A Head-to-Head Study of Donepezil, Rivastigmine, and Galantamine for the Treatment of Alzheimer's Disease: Saftey, Tolerability, Clinical and Caregiver Impression after 6 Months of Treatment: A Prospective Study of Naive Patients
Mark Pass, Joshua R. Shua-Haim
PD-059 Aging Impact on Cognitive Outcome in Schizophrenia versus Bipolar Disorder
Mircea Polosan, Thierry Gallarda, Thierry Bougerol, Jean-Pierre Olié
PD-060 A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Tolerability of Two Doses of Divalproex Sodium in Outpatients with Probable Alzheimer's Disease
L Profenno, L Jakimovich, C Holt, A Porsteinsson, P Tariot
PD-061 Can Transplanted Human Neural Stem Cells Migrate Positionally into the Cholinergic Lesioned Areas and Differentiate into Cholinergic Cells?
Tingyu Qu, Kiminobu Sugaya
PD-062 Effects of Rivastigmine Treatment on the Psychiatric and Behavioral Disturbances of Nursing Home Residents with Moderate-to-Severe Alzheimer’s Disease (Final Results)
Adrian Rabinowicz, Barbara Koumaras, Jeffrey L. Cummings, Mojtaba Noursalehi, Dario Mirski
PD-063 Differences in Circadian Rhythm in Vascular Dementia and Alzheimer's Disease
Michael Rapp, Hans Gutzmann
PD-064 An Open Label Pilot Study of Mirtazapine for the Treatment of Dementia-Associated Behavioral Problems
William E. Reichman, Julie Coleman, Peter Aupperle, Steven Sohnle
PD-065 Donepezil Treatment of Neuropsychiatric Symptoms in Nursing Home Patients Suffering from Dementia
François Rousseau, Evelyn E. Keller, Stéphane Tanguay, David Andrew Gold, Isabelle Lussier, Catherine Brassard, Nadine Gagnon, Michelle Houde
PD-066 Evolution of an Elder Specific Substance Abuse Program: Get Smart – A Ten Year Retrospective
Catherine McKean Royer, Joel Rosansky, Elvira E. Jimenez, Lissy Jarvik
PD-067 Clinical Characteristics and Hospital Based Resource Use Among Older Adults with Bipolar Disorder, Schizophrenia and Schizoaffective Disorder, Depression, and Dementia
Martha Sajatovic, Susan Hatters Friedman, Josephine Sabharwal, C. Raymond Bingham
PD-068 An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment for treatment of Alzheimer's disease
Joshua R. Shua-Haim, Mark Pass
PD-069 Safety and Tolerability of High Dose Donepezil in Patients with Alzheimer’s disease: A Preliminary Report of A Pilot Study
Joshua R. Shua-Haim, Mark Pass, Sameer Patel
PD-070 Plasma Amyloid Beta Peptides Levels in Sporadic Alzheimer's Disease and Amnestic Mild Cognitive Impairment
Tomasz Sobow, Iwona Kloszewska
PD-071 Modulation of Ionic Currents by Donepezil
Elena Solntseva, Julia Bukanova, Anna Chechulina
PD-072 A Study on Mental Health in Community Dwelling Elderly People in Korea
Kim Sung-Wan, Bae Ahn, Kim Myoung-Kyu
PD-073 Modified Tau Protein in CSF for Diagnosis of Alzheimer's Disease
Toshihisa Tanaka, Hidenaga Yamamori, Masatoshi Takeda
PD-074 Behavioral and Psychological Symptoms in Alzheimer's Disease: A Study of Frequency in a Brazilian Outpatient Sample
Mariana Franciosi Tatsch, Renata Avila, Eduardo Vilodres Campanha, Sonia Edda Zevallos Bustamante, Mário Rodrigues Louzã, Cássio Machado de Campos Bottino
PD-075 The Distribution of Cerebral Amyloid Angiopathy within the Brain with Alzheimer's Disease May be Influenced by Apolipoprotein E4
Jinzhou Tian, Jing Shi, Corinne L Lendon, Stuart M Pickering-Brown, David M A Mann
PD-076 Efficacy of Risperidone for Treating Patients with BPSD
Johannes Wancata
PD-077 A Brain Evoked Potential Examination in Alzheimer's Disease, Mild Cognitive Impairment, and Normal Control
Shifu Xiao, Xingshi Chen
PD-078 Measurement of Regional Cerebral Metabolism Rate of Glucose in Patients with Alzheimer's Disease
Shifu Xiao, Qiuyun Cao, kaida Jiang
PD-079 Heterogeneity of Questionable Dementia
Jong-Chul Youn, Ki-Woong Kim, Dong-Young Lee, Jin-Hyeong Jhoo, Jung-Hee Lee, Yong Ho Jeon, Kwan-Woo Seo, Yong-Su Paek, Il-Han Chiu, Jong-Inn Woo

Back to The Eleventh International Congress